RCT of Efficacy and Safety of CP003 on CFS/ME or Post-COVID Fatigue
NCT06739720
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
NOT_YET_RECRUITING
Status
130
Enrollment
OTHER
Sponsor class
Conditions
Chronic Fatigue Syndrome (CFS)
Post-COVID ME/CFS
Interventions
DRUG:
LingZhi capsule
Sponsor
The University of Hong Kong
Collaborators
[object Object]